Drug profile · INN
aficamten
MYQORZO
aficamten (MYQORZO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
FDA: approved EMA: approved
US status approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — aficamten
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
aficamten (MYQORZO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN aficamten
Brand MYQORZO
Route ORAL
Formulation TABLET
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Frequently asked questions
What is aficamten?
aficamten (MYQORZO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aficamten?
MYQORZO is a marketed brand name for aficamten. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aficamten?
aficamten has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.